Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 110

Results For "IND"

6284 News Found

India observes its first `Prediabetes Day' on August 14
Healthcare | August 14, 2021

India observes its first `Prediabetes Day' on August 14

Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes


Indian Immunologicals receive manufacturing license for Covaxin drug substance
Biotech | August 14, 2021

Indian Immunologicals receive manufacturing license for Covaxin drug substance

It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin


Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
News | August 13, 2021

Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores

The acquisition will provide it with a foothold in the US $ 48 billion global animal health market


USFDA grants distinct indication for Chronic Sleep Disorder
Drug Approval | August 13, 2021

USFDA grants distinct indication for Chronic Sleep Disorder

Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder


Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22
News | August 13, 2021

Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22

EPS stood at Rs 3.18


Indian pharma market grew by 13.7% in July 2021: Ind-Ra
News | August 12, 2021

Indian pharma market grew by 13.7% in July 2021: Ind-Ra

Demand normalisation post the second wave contributed to the steady growth


SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants
Drug Approval | August 12, 2021

SAB Biotherapeutics nonclinical data indicates SAB-185 neutralizes Delta and Lambda SARS-CoV-2 Variants

SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial


Merck launches New Pergoveris Pen for fertility treatment in India
Healthcare | August 10, 2021

Merck launches New Pergoveris Pen for fertility treatment in India

A globally approved pen filled by mass technology provides a safer self- administration fertility solution


Hinduja Global Solutions sells its healthcare services to Barings for US $ 1.2 billion
Digitisation | August 10, 2021

Hinduja Global Solutions sells its healthcare services to Barings for US $ 1.2 billion

The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries


Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Drug Approval | August 09, 2021

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.